Net profit of Cohance Lifesciences declined 21.29% to Rs 42.01 crore in the quarter ended March 2025 as against Rs 53.37 crore during the previous quarter ended March 2024. Sales rose 58.95% to Rs 402.02 crore in the quarter ended March 2025 as against Rs 252.93 crore during the previous quarter ended March 2024.
For the full year,net profit declined 10.79% to Rs 267.87 crore in the year ended March 2025 as against Rs 300.28 crore during the previous year ended March 2024. Sales rose 13.91% to Rs 1197.58 crore in the year ended March 2025 as against Rs 1051.35 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 402.02 | 252.93 | 59 | 1197.58 | 1051.35 | 14 |
| OPM % | 18.30 | 29.00 | - | 31.33 | 38.60 | - |
| PBDT | 78.38 | 88.10 | -11 | 421.41 | 460.27 | -8 |
| PBT | 51.60 | 70.85 | -27 | 343.92 | 405.67 | -15 |
| NP | 42.01 | 53.37 | -21 | 267.87 | 300.28 | -11 |